Cargando…

Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases

BACKGROUND: Oral lichen planus (OLP) is seen frequently in patients with hepatitis C virus (HCV) infection. The aim of this study was to evaluate the occurrence of oral candidiasis, other mucosal lesions, and xerostomia during interferon (IFN) therapy for HCV infection. METHODS: Of 124 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Yumiko, Hashimoto, Kouji, Sata, Michio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503792/ https://www.ncbi.nlm.nih.gov/pubmed/23122361 http://dx.doi.org/10.1186/1471-230X-12-155

Ejemplares similares

Dental problems delaying the initiation of interferon therapy for HCV-infected patients
por: Nagao, Yumiko, et al.
Publicado: (2010)

Analysis of the factors motivating HCV-infected patients to accept interferon therapy
por: Nagao, Yumiko, et al.
Publicado: (2012)

Effect of oral care gel on the quality of life for oral lichen planus in patients with chronic HCV infection
por: Nagao, Yumiko, et al.
Publicado: (2011)

Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
por: Nagao, Yumiko, et al.
Publicado: (2014)

Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
por: Nagao, Yumiko, et al.
Publicado: (2010)

Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals
por: Nagao, Yumiko, et al.
Publicado: (2016)

Disappearance of Oral Lichen Planus After Liver Transplantation for Primary Biliary Cirrhosis and Immunosuppressive Therapy in a 63-year-Old Japanese Woman
por: Nagao, Yumiko, et al.
Publicado: (2014)

Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study
por: Nagao, Yumiko, et al.
Publicado: (2012)

A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus
por: Nagao, Yumiko, et al.
Publicado: (2012)

Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia
por: Kawaguchi, Takumi, et al.
Publicado: (2019)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients
por: Yamasaki, Kazumi, et al.
Publicado: (2012)

Effect of Oral Care Gel for Burning Mouth Syndrome in a Patient with Hepatitis C: A Case Report
por: Nagao, Yumiko, et al.
Publicado: (2017)

Systemic hematogenous dissemination of mouse oral candidiasis is induced by oral mucositis
por: Katagiri, Hiroki, et al.
Publicado: (2018)

Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report
por: Misaka, Kenji, et al.
Publicado: (2016)

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
por: Nagao, Yumiko, et al.
Publicado: (2017)

Oral Mucosal Lesions in Childhood
por: Horvat Aleksijević, Lorena, et al.
Publicado: (2022)

A retrospective study of factors associated with the development of oral candidiasis in patients receiving radiotherapy for head and neck cancer: Is topical steroid therapy a risk factor for oral candidiasis?
por: Kawashita, Yumiko, et al.
Publicado: (2018)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

Candidiasis and Other Emerging Yeasts
por: Sharma, Megha, et al.
Publicado: (2023)

Immunology of oral candidiasis
por: Dineshshankar, Janardhanam, et al.
Publicado: (2014)

Oral candidiasis: An overview
por: Singh, Arun, et al.
Publicado: (2014)

Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
por: Van, Nguyen Dinh, et al.
Publicado: (2016)

Epidemiology of Oral Mucosal Lesions in Slovenia
por: Kansky, Andrej Aleksander, et al.
Publicado: (2018)

Taste Disorders and Oral Mucosal Lesions
Publicado: (2021)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
por: Muazzam, Ambreen G, et al.
Publicado: (2011)

Interferon Alpha Therapy in Patients with Chronic Type C Hepatitis: Changes of Serum ALT, Anti-HCV & HCV-RNA
por: Cho, Ho Jun, et al.
Publicado: (1992)

Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis
por: Chandra, Partha K., et al.
Publicado: (2014)

Mucosal Bacteria Modulate Candida albicans Virulence in Oropharyngeal Candidiasis
por: Bertolini, M., et al.
Publicado: (2021)

Conventional and alternative antifungal therapies to oral candidiasis
por: Anibal, Paula Cristina, et al.
Publicado: (2010)

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin
por: Toyoda, Hidenori, et al.
Publicado: (2012)

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
por: Conti, Heather R., et al.
Publicado: (2009)

The IL-20RB receptor and the IL-20 signaling pathway in regulating host defense in oral mucosal candidiasis
por: Beute, John E., et al.
Publicado: (2022)

Correction: Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis
Publicado: (2014)

Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK)
por: Ahmad, Bashir, et al.
Publicado: (2012)

Invasive candidiasis leading to gastric perforation in an immunocompromised patient
por: Karasuno, Takahiro, et al.
Publicado: (2019)

New Approaches in the Development of a Vaccine for Mucosal Candidiasis: Progress and Challenges
por: Vecchiarelli, Anna, et al.
Publicado: (2012)

Interferon: A Sharp Sword to Overcome HCV or HBV-Related Liver Diseases?
por: Jia, Wei-Dong, et al.
Publicado: (2010)

Oral Microbiota Composition and Function Changes During Chronic Erythematous Candidiasis
por: Lyu, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2211k4qoc5p6j2kipo9o0i0ga0